These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29328435)

  • 41. Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.
    Daga M; Pizzimenti S; Dianzani C; Cucci MA; Cavalli R; Grattarola M; Ferrara B; Scariot V; Trotta F; Barrera G
    Phytomedicine; 2019 Mar; 56():156-164. PubMed ID: 30668336
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression and Functions of Formyl Peptide Receptor 1 in Drug-Resistant Bladder Cancer.
    Jiang X; Lei T; Zhang M
    Technol Cancer Res Treat; 2018 Jan; 17():1533034618769413. PubMed ID: 29665744
    [TBL] [Abstract][Full Text] [Related]  

  • 43. microRNA-21 modulates cell proliferation and sensitivity to doxorubicin in bladder cancer cells.
    Tao J; Lu Q; Wu D; Li P; Xu B; Qing W; Wang M; Zhang Z; Zhang W
    Oncol Rep; 2011 Jun; 25(6):1721-9. PubMed ID: 21468550
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PRDX2 regulates stemness contributing to cisplatin resistance and metastasis in bladder cancer.
    Li P; Wang W; Zhu B; Wang Y; Li J; Wang C; Wang C; Li Q
    Environ Toxicol; 2024 May; 39(5):2869-2880. PubMed ID: 38294069
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
    Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
    Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased miR-323a induces bladder cancer cell apoptosis by suppressing c-Met.
    Qiu J; Zeng FR; Fang Y; Li J; Xiao SY
    Kaohsiung J Med Sci; 2019 Sep; 35(9):542-549. PubMed ID: 31180621
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enforced expression of miR-101 enhances cisplatin sensitivity in human bladder cancer cells by modulating the cyclooxygenase-2 pathway.
    Bu Q; Fang Y; Cao Y; Chen Q; Liu Y
    Mol Med Rep; 2014 Oct; 10(4):2203-9. PubMed ID: 25109742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.
    Polytarchou C; Hommes DW; Palumbo T; Hatziapostolou M; Koutsioumpa M; Koukos G; van der Meulen-de Jong AE; Oikonomopoulos A; van Deen WK; Vorvis C; Serebrennikova OB; Birli E; Choi J; Chang L; Anton PA; Tsichlis PN; Pothoulakis C; Verspaget HW; Iliopoulos D
    Gastroenterology; 2015 Oct; 149(4):981-92.e11. PubMed ID: 26055138
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NF-κB signaling plays irreplaceable roles in cisplatin-induced bladder cancer chemoresistance and tumor progression.
    Sun Y; Guan Z; Liang L; Cheng Y; Zhou J; Li J; Xu Y
    Int J Oncol; 2016 Jan; 48(1):225-34. PubMed ID: 26647959
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
    Liu X; Li G
    Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
    Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
    Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 53. VEGF-C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin.
    Zhu H; Yun F; Shi X; Wang D
    Mol Med Rep; 2015 Aug; 12(2):3163-9. PubMed ID: 25936422
    [TBL] [Abstract][Full Text] [Related]  

  • 54.  Effect of siRNA targeting EZH2 on cell viability and apoptosis of bladder cancer T24 cells.
    Wang HF; Yang H; Hu LB; Lei YH; Qin Y; Li J; Bi CW; Wang JS; Huo Q
    Genet Mol Res; 2014 Nov; 13(4):9939-50. PubMed ID: 25501205
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overexpression of miR‑214 promotes the progression of human osteosarcoma by regulating the Wnt/β‑catenin signaling pathway.
    Zhu XB; Zhang ZC; Han GS; Han JZ; Qiu DP
    Mol Med Rep; 2017 Apr; 15(4):1884-1892. PubMed ID: 28260089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
    Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
    [TBL] [Abstract][Full Text] [Related]  

  • 57. mTORC2 activation is regulated by the urokinase receptor (uPAR) in bladder cancer.
    Hau AM; Leivo MZ; Gilder AS; Hu JJ; Gonias SL; Hansel DE
    Cell Signal; 2017 Jan; 29():96-106. PubMed ID: 27777073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unveiling the role of RAC3 in the growth and invasion of cisplatin-resistant bladder cancer cells.
    Li H; Ma H; Ma J; Qin F; Fan S; Kong S; Zhao S; Ma J
    J Cell Mol Med; 2024 Jun; 28(11):e18473. PubMed ID: 38847477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Catalpol Inhibited the Proliferation of T24 Human Bladder Cancer Cells by Inducing Apoptosis Through the Blockade of Akt-Mediated Anti-apoptotic Signaling.
    Jin D; Cao M; Mu X; Yang G; Xue W; Huang Y; Chen H
    Cell Biochem Biophys; 2015 Apr; 71(3):1349-56. PubMed ID: 25388838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA‑214 suppresses propofol‑induced neuroapoptosis through activation of phosphoinositide 3‑kinase/protein kinase B signaling by targeting phosphatase and tensin homolog expression.
    Guo X; Cheng M; Ke W; Wang Y; Ji X
    Int J Mol Med; 2018 Nov; 42(5):2527-2537. PubMed ID: 30106086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.